Oral composition to reduce cold symptoms and duration of same
An oral spray composition for preventing and/or reducing the symptoms of the common cold including a zinc formulation containing both zinc acetate and zinc gluconate to ensure sustained availability of increased amounts of ionizable zinc.
1. A composition for delivering an active substance to at least one of an oral membrane, an oral pharyngeal membrane and a nasal membrane by administration through the oral cavity, said composition consisting essentially of:
at least 84 weight percent of a pharmaceutically acceptable liquid carrier;
about 0.8 to about 1.2 weight percent stabilizer;
a sweetener;
about 0.01 to about 0.02 weight percent preservative;
about 0.5 to about 2 weight percent flavor enhancer; and
a zinc formulation consisting of at least 2 weight percent zinc gluconate in the composition and about 0.2 to about 2 weight percent zinc acetate in the composition, said zinc gluconate and said zinc acetate ionized in the liquid carrier.
2. The composition of claim 1 , wherein in said composition free ionic zinc is present in an amount of about 3 to about 7 mg/ml.
3. The composition of claim 1 , wherein said composition is an oral spray.
4. The composition of claim 1 , wherein said pharmaceutically acceptable liquid carrier is present in an amount of about 84 to 88 weight percent of said composition.
5. The composition of claim 4 , wherein said pharmaceutically acceptable liquid carrier is purified water.
6. The composition of claim 1 , wherein said zinc formulation is present in an amount of about 3 to 6 weight percent of said composition.
7. The composition of claim 1 , wherein said stabilizer is glycerin.
8. The composition of claim 1 wherein said sweetener is selected from at least one of the following: fructose and dextrose.
9. The composition of claim 1 , wherein said preservative is selected from at least one of the following: benzalkonium chloride and benzyl alcohol.
10. A composition for delivering an active substance to at least one of an oral, an oralpharyngeal, and a nasal membrane by administration through the mouth, said composition consisting essentially of:
at least about 84 weight percent of a pharmaceutically acceptable liquid carrier;
about 0.8 to about 1.2 weight percent a stabilizer;
sweetener;
preservative;
flavor enhancer; and
a zinc formulation consisting of than at least 2 weight percent of zinc gluconate and about 0.2 to about 2.0 weight percent of zinc acetate, wherein said zinc gluconate and said zinc acetate are ionized in said pharmaceutically acceptable liquid carrier.
11. The composition of claim 10 , wherein in said composition free ionic zinc is present in an amount of about 3 to about 7 mg/ml.
12. The composition of claim 10 , wherein said composition is an oral spray.
13. The composition of claim 10 , wherein said pharmaceutically acceptable liquid carrier is present in an amount of about 84 to 88 weight percent of said composition.
14. The composition of claim 13 , wherein said pharmaceutically acceptable carrier is purified water.
15. The composition of claim 10 , wherein said zinc formulation is present in an amount of about 2 to 6 weight percent of said composition.
16. The composition of claim 10 , wherein said stabilizer is glycerin.
17. The composition of claim 10 wherein said sweetener is selected from at least one of the following: fructose and dextrose.
18. The composition of claim 10 , wherein said preservative is selected from at least one of the following: benzalkonium chloride and benzyl alcohol.
19. The composition of claim 18 , wherein said benzalkonium chloride is present in an amount of about 0.01 to about 0.02 weight percent.
20. The composition of claim 10 , wherein said flavor enhancer is present in an amount of about 0.5 to about 2 weight percent of said composition.